A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST).
Cappello G, Giannini V, Cannella R, Tabone E, Ambrosini I, Molea F, Damiani N, Landolfi I, Serra G, Porrello G, Gozzo C, Incorvaia L, Badalamenti G, Grignani G, Merlini A, D'Ambrosio L, Bartolotta TV, Regge D.
Cappello G, et al. Among authors: bartolotta tv.
Eur J Radiol Open. 2023 Jul 10;11:100505. doi: 10.1016/j.ejro.2023.100505. eCollection 2023 Dec.
Eur J Radiol Open. 2023.
PMID: 37484979
Free PMC article.